11 Best NASDAQ Stocks Under $5 to Buy Now

Page 10 of 10

1. Rocket Pharmaceuticals Inc. (NASDAQ:RCKT)

Share Price as of October 23: $3.80

Number of Hedge Fund Holders: 38

Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the best NASDAQ stocks under $5 to buy now. On October 14, Rocket Pharmaceuticals announced that the US FDA accepted the resubmission of the Biologics License Application/BLA for KRESLADI (marnetegragene autotemcel; marne-cel).

KRESLADI is a lentiviral vector/LV-based investigational gene therapy intended for the treatment of severe Leukocyte Adhesion Deficiency-I (LAD-I), which is a rare genetic immune disorder. The BLA resubmission is supported by positive clinical efficacy and safety data from the global Phase 1/2 study of KRESLADI.

The study achieved 100% overall survival at 12 months post-infusion (and for the entire duration of follow-up) for all enrolled patients. All primary and secondary endpoints were met, and the therapy was well tolerated with no treatment-related serious adverse events reported. Data showed substantial reductions in the incidence of significant infections compared to pre-treatment levels, along with evidence of improved skin lesions and restored wound-healing capabilities.

Rocket Pharmaceuticals Inc. (NASDAQ:RCKT), together with its subsidiaries, operates as a late-stage biotechnology company that develops gene therapies for rare and devastating diseases in the US.

While we acknowledge the potential of RCKT to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than RCKT and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 10 of 10